These patients also showed improved systolic Trusted Source Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D
Below is a summary of the relevant clinical findings: Safety and Tolerability CT-388 was generally well tolerated in both single ascending dose (SAD) and multiple ascending dose (MAD) portions of the trial
Consistency is the most important factor in achieving long-term results
Oral semaglutide starts working for weight loss soon after you take it, reaching its peak concentration in your bloodstream within one hour